The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
Open accessAbstract
Degradation of extracellular matrix is crucial for malignant tumour growth, invasion, metastasis and angiogenesis. Matrix metalloproteinases (MMPs) are a family of zinc‐dependent neutral endopeptidases collectively capable of degrading essentially all matrix components. Elevated levels of distinct MMPs can be detected in tumour tissue or serum of patients with advanced cancer and their role as prognostic indicators in cancer is studied. In addition, therapeutic intervention of tumour growth and invasion based on inhibition of MMP activity is under intensive investigation and several MMP inhibitors are in clinical trials in cancer. In this review, we discuss the current view on the feasibility of MMPs as prognostic markers and as targets for therapeutic intervention in cancer. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,908
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494
Self-citationA novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., & Chambon, P. (1990) · Nature · doi:10.1038/348699a0 · Cited by 1,131
Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., López-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M., & Parks, W. C. (1999) · Science · doi:10.1126/science.286.5437.113 · Cited by 1,074
Hortobagyi, G. N., Theriault, R. L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J., Knight, R. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352401 · Cited by 1,026
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.
Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., & Itohara, S. (1998) · PubMed · Cited by 875
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hidalgo, M., & Eckhardt, S. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.178 · Cited by 798
Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Pepper, M. S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.093685 · Cited by 777
Freije, J. M., Díez-Itza, I., Balbín, M., Sánchez, L. M., Blasco, R., Tolivia, J., & López-Otín, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89457-7 · Cited by 762
Matrix metalloproteinase degradation of extracellular matrix: biological consequences
Shapiro, S. D. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80035-5 · Cited by 716
Biswas, C., Zhang, Y., DeCastro, R., Guo, H., Nakamura, T., Kataoka, H., & Nabeshima, K. (1995) · PubMed · Cited by 716
Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins
Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., & Weiss, S. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81768-7 · Cited by 712
Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., & Tryggvason, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060037197 · Cited by 666
Furin-dependent intracellular activation of the human stromelysin-3 zymogen
Pei, D., & Weiss, S. J. (1995) · Nature · doi:10.1038/375244a0 · Cited by 629
Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin
Wilson, C. L., Heppner, K. J., Labosky, P. A., Hogan, B. L. M., & Matrisian, L. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1402 · Cited by 609
Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
Zucker, S., Cao, J., & Chen, W.-T. (2000) · Oncogene · doi:10.1038/sj.onc.1204097 · Cited by 550
Curran, S., & Murray, G. I. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00156-8 · Cited by 531
Rutter, J. L., Mitchell, T. I., Butticè, G., Meyers, J., Gusella, J. F., Ozelius, L. J., & Brinckerhoff, C. (1998) · PubMed · Cited by 531
Dong, Z., Kumar, R., Yang, X., & Fidler, I. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81926-1 · Cited by 525
Okada, A., Bellocq, J. P., Rouyer, N., Chenard, M. P., Rio, M. C., Chambon, P., & Basset, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2730 · Cited by 499
Shapiro, S. D., Kobayashi, D. K., & Ley, T. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80459-1 · Cited by 489
Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer
Murray, G. I., Duncan, M. E., O'Neil, P., Melvin, W. T., & Fothergill, J. E. (1996) · Nature Medicine · doi:10.1038/nm0496–461 · Cited by 481
Bramhall, S. R., Rosemurgy, A., Brown, P. D., Bowry, C., Buckels, J. A. C., & for the Marimastat Pancreatic Cancer Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3447 · Cited by 438
Patterson, B. C., & Sang, Q. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28823 · Cited by 433
Kähäri, V.-M., & Saarialho-Kere, U. (1999) · Annals of Medicine · doi:10.3109/07853899909019260 · Cited by 408
Self-citationSchmalfeldt, B., Prechtel, D., Härting, K., Späthe, K., Rutke, S., Konik, E., Fridman, R., Berger, U., Schmitt, M., Kuhn, W. C., et al. (2001) · PubMed · Cited by 334
Kim, Y. M., Jang, J.-W., Lee, O., Yeon, J.-H., Choi, E.-Y., Kim, K., Lee, S., & Kwon, Y. (2000) · PubMed · Cited by 317
Experimental metastasis is suppressed in MMP-9-deficient mice
Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., & Uehira, M. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006603723759 · Cited by 308
Role of Matrix Metalloproteinases in Abdominal Aortic Aneurysmsa
THOMPSON, R. W., & PARKS, W. C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb33307.x · Cited by 306
Membrane‐type matrix metalloproteinases
SEIKI, M. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01536.x · Cited by 300
Zucker, S., Lysik, R. M., Zarrabi, M. H., & Moll, U. M. (1993) · PubMed · Cited by 296
Masson, R., Lefebvre, O., Noël, A., Fahime, M. E., Chenard, M.-P., Wendling, C., Kebers, F., LeMeur, M., Dierich, A., Foidart, J.-M., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.6.1535 · Cited by 291
Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer
Murray, G. I., Duncan, M. E., O'Neil, P., McKay, J. A., Melvin, W. T., & Fothergill, J. E. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<256::aid-path115>3.0.co;2-a · Cited by 288
Kurahara, S., Shinohara, M., Ikebe, T., Nakamura, S., Beppu, M., Hiraki, A., Takeuchi, H., & Shirasuna, K. (1999) · Head & Neck · doi:10.1002/(sici)1097-0347(199910)21:7<627::aid-hed7>3.0.co;2-2 · Cited by 271
Wojtowicz-Praga, S., Torri, J., Johnson, M., Steen, V, Marshall, J., Ness, E., Dickson, R., Sale, M., Rasmussen, H. S., Chiodo, T. A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2150 · Cited by 252
Pendás, A. M., Knäuper, V., Puente, X. S., Llano, E., Mattei, M.-G., Apte, S., Murphy, G., & López-Otín, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4281 · Cited by 252
Johansson, N., Airola, K., Grenman, R. A., Kariniemi, A. L., Saarialho‐Kere, U., & Kähäri, V. (1997) · Europe PMC (PubMed Central) · Cited by 246
Self-citationSHALINSKY, D. R., BREKKEN, J., ZOU, H., MCDERMOTT, C. D., FORSYTH, P., EDWARDS, D., MARGOSIAK, S., BENDER, S., TRUITT, G., WOOD, A., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07689.x · Cited by 239
ZUCKER, S., HYMOWITZ, M., CONNER, C., ZARRABI, H. M., HUREWITZ, A. N., MATRISIAN, L., BOYD, D., NICOLSON, G., & MONTANA, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07687.x · Cited by 236
Velasco, G., Pendás, A. M., Fueyo, A., Knäuper, V., Murphy, G., & López-Otı́n, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4570 · Cited by 234
Airola, K., Karonen, T., Vaalamo, M., Lehti, K., Lohi, J., Kariniemi, A.-L., Keski-Oja, J., & Saarialho-Kere, U. K. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690417 · Cited by 227
Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast carcinoma
Talvensaari-Mattila, A., P��kk�, P., H�yhty�, M., Blanco-Sequeiros, G., & Turpeenniemi-Hujanen, T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980915)83:6<1153::aid-cncr14>3.0.co;2-4 · Cited by 217
Uría, J. A., & López-Otín, C. (2000) · PubMed · Cited by 206
MMP Inhibition and Downregulation by Bisphosphonates
TERONEN, O., HEIKKILÄ, P., KONTTINEN, Y. T., LAITINEN, M., SALO, T., HANEMAAIJER, R., TERONEN, A., MAISI, P., & SORSA, T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07702.x · Cited by 200
Cox, G., Jones, J. L., & O'Byrne, K. J. (2000) · PubMed · Cited by 197
Slaton, J. W., Inoue, K., Perrotte, P., El-Naggar, A. K., Swanson, D. A., Fidler, I. J., & Dinney, C. P. N. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64016-3 · Cited by 195
Kanayama, H., Yokota, K., Kurokawa, Y., Murakami, Y., Nishitani, M., & Kagawa, S. (1998) · Cancer · Cited by 187
Generation of an Angiostatin-like Fragment from Plasminogen by Stromelysin-1 (MMP-3)
Lijnen, H. R., Ugwu, F., Bini, A., & Collen, D. (1998) · Biochemistry · doi:10.1021/bi9731798 · Cited by 185
Davidson, B., Goldberg, I., Gotlieb, W. H., Kopolovic, J., Ben-Baruch, G., Nesland, J. M., Berner, A., Bryne, M., & Reich, R. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006723011835 · Cited by 183
Määttä, M., Soini, Y., Liakka, A., & Autio‐Harmainen, H. (2000) · PubMed · Cited by 178
Human Collagenase-3 Is Expressed in Malignant Squamous Epithelium of the Skin
Airola, K., Johansson, N., Kariniemi, A.-L., Kähäri, V.-M., & Saarialho-Kere, U. K. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12319441 · Cited by 175
Self-citationYamamoto, H., Itoh, F., Iku, S., Adachi, Y., Fukushima, H., Sasaki, S., Mukaiya, M., Hirata, K., & Imai, K. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.1118 · Cited by 173
Ylisirniö, S., Höyhtyä, M., & Turpeenniemi-Hujanen, T. M. (2000) · PubMed · Cited by 171
Matrix Metalloproteinase Matrilysin Is Constitutively Expressed in Adult Human Exocrine Epithelium
Saarialho-Kere, U. K., Crouch, E. C., & Parks, W. C. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12317104 · Cited by 167
Ongoing trials with matrix metalloproteinase inhibitors
Brown, P. D. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.9.2167 · Cited by 167
Macaulay, V. M., O'Byrne, K. J., Saunders, M. P., et al. (1999) · PubMed · Cited by 161
Michael, M., Babic, B., Khokha, R., Tsao, M., Ho, J., Pintilie, M., Leco, K., Chamberlain, D., & Shepherd, F. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1802 · Cited by 160
Koshiba, T., Hosotani, R., Wada, M., Miyamoto, Y., Fujimoto, K., Lee, J.-U., Doi, R., Arii, S., & Imamura, M. (1998) · Cancer · Cited by 155
Ghilardi, G., Biondi, M. L., Mangoni, J., et al. (2001) · PubMed · Cited by 154
Rudek, M. A., Figg, W. D., Dyer, V., Dahut, W. L., Turner, M. L. C., Steinberg, S. M., Liewehr, D. J., Köhler, D., Pluda, J. M., & Reed, E. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.584 · Cited by 153
Westermarck, J. K., Seth, A. K., & Kähäri, V. (1997) · Oncogene · doi:10.1038/sj.onc.1201111 · Cited by 149
Self-citationLevitt, N. C., Eskens, F. A. L. M., O'Byrne, K. J., PROPPER, D. J., Denis, L. J., Owen, S., Choi, L., Foekens, J. A., Wilner, S., Wood, J. M., et al. (2001) · PubMed · Cited by 136
Väisänen, A., Kallioinen, M., Taskinen, P. J., & Turpeenniemi-Hujanen, T. (1998) · The Journal of Pathology · Cited by 134
Gohji, K., Fujimoto, N., Hara, I., Fujii, A., Gotoh, A., Okada, H., Arakawa, S., Kitazawa, S., Miyake, H., Kamidono, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1<96::aid-ijc18>3.0.co;2-f · Cited by 134
Passlick, B., Sienel, W. G. R., Seen-Hibler, R., Wöckel, W., Thetter, O., Mutschler, W., & Pantel, K. (2000) · PubMed · Cited by 134
Collagenase-3 (MMP-13) is Expressed by Tumor Cells in Invasive Vulvar Squamous Cell Carcinomas
Johansson, N., Vaalamo, M., Grénman, S., Hietanen, S., Klemi, P. J., Saarialho‐Kere, U., & Kähäri, V. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65293-5 · Cited by 131
Self-citationMatrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz, P., Sawicki, G., Duszyk, M., Sawicka, J. M., Miranda, C., Mayers, I., & Radomski, M. W. (2001) · PubMed · Cited by 129
Ohashi, K., Nemoto, T., Nakamura, K., & Nemori, R. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2201::aid-cncr2>3.0.co;2-n · Cited by 129
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.
Krüger, A., Soeltl, R., Sopov, I., Kopitz, C., Arlt, M., Magdolen, V., Harbeck, N., Gänsbacher, B., & Schmitt, M. (2001) · PubMed · Cited by 127
Clinical studies with matrix metalloproteinase inhibitors
Brown, P. D. N. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01541.x · Cited by 126
Kuniyasu, H., Ellis, L. M., Evans, D. B., Abbruzzese, J. L., Fenoglio, C. J., Bucana, C. D., Cleary, K. R., Tahara, E., & Fidler, I. J. (1999) · PubMed · Cited by 124
Uría, J. A., Balbín, M., López, J. M., Álvarez, J., Vizoso, F. J., Takigawa, M., & López-Otín, C. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65549-6 · Cited by 121
Ye, S., Dhillon, S. S., Turner, S. T., Bateman, A. C., Theaker, J. M., Pickering, R. M., Day, I. N. M., & Howell, W. M. (2001) · PubMed · Cited by 120
Herbst, R. S., Yano, S., Kuniyasu, H., Khuri, F. R., Bucana, C. D., Guo, F., Liu, D., Kemp, B. L., Lee, J. J., Hong, W. K., et al. (2000) · PubMed · Cited by 116
Marimastat in Patients With Advanced Pancreatic Cancer
Rosemurgy, A. S., Harris, J. E., Langleben, A., et al. (1999) · American Journal of Clinical Oncology · doi:10.1097/00000421-199906000-00007 · Cited by 114
Davidson, B., Goldberg, I., Kopolovic, J., Lerner‐Geva, L., Gotlieb, W. H., Ben‐Baruch, G., & Reich, R. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5381 · Cited by 113
Beattie, G. J., & Smyth, J. F. (1998) · PubMed · Cited by 111
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity.
Gatto, C., Rieppi, M., Borsotti, P., Innocenti, S., Ceruti, R., Drudis, T., Scanziani, E., Casazza, A. M., Taraboletti, G., & Giavazzi, R. (1999) · PubMed · Cited by 107
Regulation of Matrix Metalloproteinase Activity in Ischemic Tissue by Interleukin-10
Silvestre, J., Mallat, Z., Tamarat, R., Duriez, M., Tedgui, A., & Levy, B. I. (2001) · Circulation Research · doi:10.1161/hh1501.094269 · Cited by 103
Etoh, T., Inoue, H., Yoshikawa, Y., Barnard, G. F., Kitano, S., & Mori, M. (2000) · Gut · doi:10.1136/gut.47.1.50 · Cited by 102
Expression of Human Macrophage Metalloelastase (MMP-12) by Tumor Cells in Skin Cancer
Kerkelä, E., Ala‐aho, R., Jeskanen, L., Rechardt, O., Grenman, R. A., Shapiro, S. D., Kähäri, V., & Saarialho‐Kere, U. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00993.x · Cited by 102
Self-citationRing, P., Johansson, K. A., Höyhtyä, M., Rubin, K., & Lindmark, G. E. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.466 · Cited by 93
Matrix Metalloproteinase Inhibitors: Applications in Oncology
Yip, D., Ahmad, A., Karapetis, C. S., Hawkins, C. A., & Harper, P. (1999) · Investigational New Drugs · doi:10.1023/a:1006386406584 · Cited by 89
Riedel, F., Götte, K., Schwalb, J., Bergler, W. F., & Hörmann, K. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.6.1099 · Cited by 85
Rowinsky, E. K., Humphrey, R. W., Hammond, L. A., Aylesworth, C. A., Smetzer, L., Hidalgo, M. M., Morrow, M., Smith, L. S., Garner, A. M., Sorensen, J. M., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.178 · Cited by 85
Jäälinoja, J., Herva, R., Korpela, M., Höyhtyä, M., & Turpeenniemi-Hujanen, T. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006421112839 · Cited by 82
Primrose, J. M., Bleiberg, H., Daniel, F., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690079 · Cited by 72
Westermarck, J. K., Li, S., Jaakkola, P., Kallunki, T., Grenman, R. A., & Kähäri, V. (2000) · PubMed · Cited by 47
Self-citationStearns, M. E., & Wang, M. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006524610591 · Cited by 43
Expression and role of matrix metalloproteinases MMP-2 and MMP-9 in human spinal column tumors
Gokaslan, Z. L., Chintala, S. K., York, J. E., Venkaiah, B., Jasti, S. L., Sawaya, R. A., Fuller, G. N., Wildrick, D. M., Nicolson, G. L., & Rao, J. S. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006580728338 · Cited by 39
Yamamoto, H., Itoh, F., Adachi, Y., et al. (1999) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/29.2.58 · Cited by 34
Walther, M. M., Kleiner, D. E., Lubensky, I. A., Pozzatti, R., Nyguen, T., Gnarra, J. R., Hurley, K., Venzon, D. J., Linehan, W. M., & Stetler‐Stevenson, W. G. (1997) · Urology · doi:10.1016/s0090-4295(97)00220-3 · Cited by 26
Farina, A. R., Tacconelli, A., Teti, A. M., Gulino, A., & Mackay, A. R. (1998) · PubMed · Cited by 24
Nordengren, J., Casslén, B. G., Gustavsson, B., Einarsdottir, M., & Wïllén, R. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980417)79:2<187::aid-ijc15>3.0.co;2-7 · Cited by 14
Cited by
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Extracellular matrix structure
Theocharis, A. D., Skandalis, S. S., Gialeli, C., & Karamanos, N. K. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.001 · Cited by 2,598
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
Jabłońska-Trypuć, A., Matejczyk, M., & Rosochacki, S. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1161620 · Cited by 1,042
Matrix metalloproteinases and angiogenesis
Rundhaug, J. E. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00355.x · Cited by 960
Metadata
- Authors
- Vihinen, P., & Kähäri, V.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2002-04-11
- Volume
- 99
- Issue
- 2
- Pages
- 157-166
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1963681491
- Cited by
- 637
- References
- 97
- FWCI
- 15.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.